Correlation between Change in Blood Pressure and V02max in Indian Patients of Ischemic Heart Disease after Ischemic Reversal Program Therapy

IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Research in Cardiovascular Medicine Pub Date : 2019-10-01 DOI:10.4103/rcm.rcm_11_19
R. Sane, G. Amin, Snehal Dongre, R. Mandole
{"title":"Correlation between Change in Blood Pressure and V02max in Indian Patients of Ischemic Heart Disease after Ischemic Reversal Program Therapy","authors":"R. Sane, G. Amin, Snehal Dongre, R. Mandole","doi":"10.4103/rcm.rcm_11_19","DOIUrl":null,"url":null,"abstract":"Background: The control of blood pressure (BP) is crucial in improving the outcomes of ischemic heart disease (IHD) patients. Ischemia Reversal Program (IRP) has been proved to improve the aerobic capacity of IHD patients, but further validation is needed. Methodology: This retrospective study used the data of 78 patients who had visited Madhavbaug Clinics between July and December 2018. The mean VO2max, systolic BP (SBP), and diastolic BP (DBP) with heart rate (HR) after day 30 of IRP completion was compared with that on day 1 of IRP initiation. These values were evaluated separately after classifying the patients as those being normotensive and those having either elevated BP or hypertension (HTN). Pearson's test was used to correlate the change in SBP or DBP with VO2max. Results: Majority of the patients were male (n = 54) with the mean age of 59.94 ± 9.46 years. Majority of the IHD patients had elevated BP or HTN (n = 56). The mean HR decrease in both, the normotensive group and the group with elevated BP/hypertensive patients, was found to be statistically significant at the follow-up (P < 0.05). The mean SBP (119.48 ± 12.26 mmHg vs. 135.29 ± 15.59 mmHg) and the mean DBP (77.41 ± 9.06 mmHg vs. 91.18 ± 8.86 mmHg) were significantly decreased in the hypertensive group of patients at the follow-up (P < 0.05). For the normotensive patients, they were maintained in the normal range (P > 0.05). The negative correlations of SBP (R = −0.12, P > 0.05) and DBP (R = −0.32, P < 0.05) changes with VO2maxchange were found. Conclusion: IRP increased the VO2maxand reduced the BP in IHD patients with elevated BP. The reduction in BP correlated with an increase in VO2maxin IHD patients.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/rcm.rcm_11_19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The control of blood pressure (BP) is crucial in improving the outcomes of ischemic heart disease (IHD) patients. Ischemia Reversal Program (IRP) has been proved to improve the aerobic capacity of IHD patients, but further validation is needed. Methodology: This retrospective study used the data of 78 patients who had visited Madhavbaug Clinics between July and December 2018. The mean VO2max, systolic BP (SBP), and diastolic BP (DBP) with heart rate (HR) after day 30 of IRP completion was compared with that on day 1 of IRP initiation. These values were evaluated separately after classifying the patients as those being normotensive and those having either elevated BP or hypertension (HTN). Pearson's test was used to correlate the change in SBP or DBP with VO2max. Results: Majority of the patients were male (n = 54) with the mean age of 59.94 ± 9.46 years. Majority of the IHD patients had elevated BP or HTN (n = 56). The mean HR decrease in both, the normotensive group and the group with elevated BP/hypertensive patients, was found to be statistically significant at the follow-up (P < 0.05). The mean SBP (119.48 ± 12.26 mmHg vs. 135.29 ± 15.59 mmHg) and the mean DBP (77.41 ± 9.06 mmHg vs. 91.18 ± 8.86 mmHg) were significantly decreased in the hypertensive group of patients at the follow-up (P < 0.05). For the normotensive patients, they were maintained in the normal range (P > 0.05). The negative correlations of SBP (R = −0.12, P > 0.05) and DBP (R = −0.32, P < 0.05) changes with VO2maxchange were found. Conclusion: IRP increased the VO2maxand reduced the BP in IHD patients with elevated BP. The reduction in BP correlated with an increase in VO2maxin IHD patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度缺血性心脏病患者经缺血性逆转方案治疗后血压变化与V02max的相关性
背景:控制血压对改善缺血性心脏病(IHD)患者的预后至关重要。缺血逆转程序(IRP)已被证明可以提高IHD患者的有氧能力,但还需要进一步验证。方法:这项回顾性研究使用了2018年7月至12月期间访问Madhavbaug诊所的78名患者的数据。将IRP完成后第30天的平均VO2max、收缩压(SBP)和舒张压(DBP)与心率(HR)与IRP开始后第1天的平均值进行比较。在将患者分为血压正常的患者和血压升高或高血压(HTN)的患者后,分别评估这些值。Pearson检验用于将SBP或DBP的变化与VO2max相关联。结果:患者多为男性(n=54),平均年龄59.94±9.46岁。大多数IHD患者的血压或HTN升高(n=56)。血压正常组和血压升高/高血压患者组的平均HR均降低,在随访时发现具有统计学意义(P<0.05)。高血压组患者的平均收缩压(119.48±12.26 mmHg vs.135.29±15.59 mmHg)和平均舒张压(77.41±9.06 mmHg vs 91.18±8.86 mmHg)在随访时显著降低(P<0.05),SBP(R=-0.12,P>0.05)和DBP(R=-0.32,P<0.05)变化与VO2max变化呈负相关。结论:IRP可提高血压升高的IHD患者的最大摄氧量,降低血压。IHD患者血压降低与VO2maxin增加相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Research in Cardiovascular Medicine
Research in Cardiovascular Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
13
审稿时长
17 weeks
期刊最新文献
An unusual presentation of a rare case of rhabdomyosarcoma of the left atrium as severe rheumatic mitral stenosis with atrial fibrillation, fast ventricular rate, and left atrial failure Prognostic value of cardiac and noncardiac biomarkers in infective endocarditis: A prospective cross-sectional study Transcatheter closure of the aortopulmonary window with a multifunctional occluder device Predictions of adherence to treatment in patients referred to the heart failure clinic of Shahid Rajaee Hospital in Tehran The association between statin dosage and malignant ventricular arrhythmias in patients with primary prevention implantable cardioverter-defibrillators for ischemic cardiomyopathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1